← Back to Clinical Trials
Recruiting NCT07579039

NCT07579039 Combined Effect of Prenatal Stretching and Kinesiotaping in Pregnant Women With Low Back Pain

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07579039
Status Recruiting
Phase
Sponsor Riphah International University
Condition Pain
Study Type INTERVENTIONAL
Enrollment 34 participants
Start Date 2025-08-31
Primary Completion 2026-09-30

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 35 Years
Study Type INTERVENTIONAL
Interventions
Stretching exercises and kinisiotapingStretching exercises

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 34 participants in total. It began in 2025-08-31 with a primary completion date of 2026-09-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Low back pain (LBP) is a prevalent complaint during pregnancy, affecting 50-70% of women, especially in the second and third trimesters. Physiological and biomechanical changes such as hormonal relaxation of ligaments, postural shifts, and increased lumbar lordosis contribute to this condition. LBP during pregnancy can significantly limit mobility, reduce daily activity levels, and impair the quality of life. Conservative interventions like prenatal stretching and kinesiotaping are commonly used by physiotherapists. Stretching improves flexibility and reduces musculoskeletal stress, while kinesiotaping offers support, reduces pain perception, and promotes better posture. However, there is limited clinical evidence evaluating their combined effect in pregnant women with LBP. This study will be randomized controlled trial and will be conducted at Rahim Yar Khan hospital and Hamdani Hospital Rahim Yar khan .Non-probability convenience sampling technique will be used. Inclusion criteria include Gestational age 20 -34 weeks with low back pain and age between 18-35 years .Baseline measurement include pain (measured by using 10 cm Numeric Pain rating scale ) mobility (measured by Schober Test) quality of life( SF36 questionaire). Participant will be randomly assigned to either Group A (stretching exercise and kinesiotaping) and Group B (Stretching exercise ). The total duration of the study will be 6 to 8 weeks. After identifying eligible pregnant women, obtaining informed consent, and recording baseline measurements from both groups intervention period will begin, during which participants will receive prenatal stretching and kinesiotaping. After data collection all data analysis will be performed using SPSS version 21.

Eligibility Criteria

Inclusion Criteria: * Pregnant women with clinically diagnosed low back pain * Maternal age between 18-35 years. * Gestational age between 20-34 weeks Exclusion Criteria: * High-risk pregnancy * Skin allergies (contraindicating kinesiotaping) * Previous spinal surgeries

Contact & Investigator

Central Contact

imran amjad, phd

✉ imran.amjad@riphah.edu.pk

📞 03324390125

Principal Investigator

Masooma Saleem, MSPT WH

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07579039 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07579039 currently recruiting?

Yes, NCT07579039 is actively recruiting participants. Contact the research team at imran.amjad@riphah.edu.pk for enrollment information.

Where is the NCT07579039 trial being conducted?

This trial is being conducted at Rahim Yar Khan, Pakistan.

Who is sponsoring the NCT07579039 clinical trial?

NCT07579039 is sponsored by Riphah International University. The principal investigator is Masooma Saleem, MSPT WH at Riphah International University. The trial plans to enroll 34 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology